» Articles » PMID: 27752734

Investigating the Involvement of TRPV Ion Channels in Remote Hind Limb Preconditioning-induced Cardioprotection in Rats

Overview
Specialty Pharmacology
Date 2016 Oct 19
PMID 27752734
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Remote ischemic preconditioning (RIPC) treatment strategy is a breakthrough in the field of cardiovascular pharmacology as it has the potential to attenuate myocardial ischemia-reperfusion injury. However, the underlying intracellular pathways have not been widely explored. The present study intends to explore the possible role of TRPV channels in mediating remote hind limb preconditioning-induced cardioprotection. Remote hind limb preconditioning stimulus (4 cycles in succession) was delivered by tying the blood pressure cuff at the inguinal level of the rat. The Langendorff system was used to perfuse the isolated heart and afterward was subjected to 30 min of global ischemia and 120 min of reperfusion. Sustained ischemia and, thereafter, reperfusion led to cardiac injury that was assessed in terms of infarct size, lactate dehydrogenase (LDH) release, creatine kinase (CK) release, left ventricular end diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), +dp/dt, -dp/dt heart rate, rate pressure product, and coronary flow rate. The pharmacological modulators employed included capsaicin as TRPV agonist and capsazepine as TRPV antagonist. Remote hind limb preconditioning stimulus and capsaicin preconditioning (5 and 10 mg/kg) led to significant reduction in infarct size, LVEDP, LDH release, CK release, and significant improvement in LVDP, +dp/dt, -dp/dt, heart rate, rate pressure product, and coronary flow rate. However, remote hind limb preconditioning-induced cardioprotective effects were considerably abolished in the presence of capsazepine (2.5 and 5 mg/kg). This indicates that remote hind limb preconditioning stimulus possibly activates TRPV channels to produce cardioprotective effects.

Citing Articles

TRPV1 Channels Are New Players in the Reticulum-Mitochondria Ca Coupling in a Rat Cardiomyoblast Cell Line.

Tessier N, Ducrozet M, Dia M, Badawi S, Chouabe C, Crola Da Silva C Cells. 2023; 12(18).

PMID: 37759544 PMC: 10529771. DOI: 10.3390/cells12182322.


Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature.

Kumar K, Singh N, Jaggi A, Maslov L Curr Cardiol Rev. 2020; 17(3):306-318.

PMID: 33109063 PMC: 8640861. DOI: 10.2174/1573403X16999200817170619.


Effect of Remote Ischemic Conditioning in Patients With Takotsubo Syndrome After Acute Stroke: Study Protocol for a Randomized Controlled Trial.

Wang T, Xu Y, Wang N, Qi M, Cheng W, Qu X Front Neurol. 2020; 11:286.

PMID: 32425872 PMC: 7212382. DOI: 10.3389/fneur.2020.00286.


Investigating the role of acute and repeated stress on remote ischemic preconditioning-induced cardioprotection.

Tyagi S, Kaur S, Singh N, Jaggi A Iran J Basic Med Sci. 2020; 23(1):111-116.

PMID: 32395208 PMC: 7206844. DOI: 10.22038/IJBMS.2019.36416.8678.


Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart.

Gorbunov A, Maslov L, Jaggi A, Singh N, De Petrocellis L, Boshchenko A Curr Cardiol Rev. 2019; 15(4):244-251.

PMID: 30848206 PMC: 8142357. DOI: 10.2174/1573403X15666190307112326.


References
1.
Kaszas K, Keller J, Coddou C, Mishra S, Hoon M, Stojilkovic S . Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther. 2011; 340(1):152-60. PMC: 3251023. DOI: 10.1124/jpet.111.183053. View

2.
Randhawa P, Jaggi A . Gadolinium and ruthenium red attenuate remote hind limb preconditioning-induced cardioprotection: possible role of TRP and especially TRPV channels. Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(8):887-96. DOI: 10.1007/s00210-016-1251-5. View

3.
Lu M, Chen Y, Huang H, Ma M . Hypoxic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway. Basic Res Cardiol. 2014; 109(4):414. DOI: 10.1007/s00395-014-0414-0. View

4.
Peng J, Li Y . The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection. Eur J Pharmacol. 2009; 627(1-3):1-7. DOI: 10.1016/j.ejphar.2009.10.053. View

5.
Harper A, Brownlow S, Sage S . A role for TRPV1 in agonist-evoked activation of human platelets. J Thromb Haemost. 2008; 7(2):330-8. DOI: 10.1111/j.1538-7836.2008.03231.x. View